Kazem Kazempour, CEO and President of Amarex Clinical Research, LLC, co-founded the company in 1998, which became part of NSF International in 2019. He has over 30 years of experience in clinical research. His experience includes conducting clinical research activities with the National Institutes of Health (NIH) and numerous other research centers. Dr. Kazempour has presented to the U.S. FDA on more than 100 clinical products and to other regulatory agencies in both Europe and Asia. He has also participated in many DSMBs and has worked in a variety of therapeutic areas, including vaccines, anti-infectives, anti-virals, AIDS and cardiovascular diseases.
His areas of expertise include:
- Adaptive trial design
- Regulatory strategy
- Presentations to FDA advisory committees (statistical analysis and planning)
- Clinical trial development